• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺癌公共数据集的综合分析揭示了转录后调控通过靶向免疫系统介质对肿瘤进展的作用。

Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.

作者信息

Geraldo Murilo V, Kimura Edna T

机构信息

Department of Cell and Developmental Biology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo, Brazil.

Department of Structural and Functional Biology, Institute of Biology, State University of Campinas, Campinas, Brazil.

出版信息

PLoS One. 2015 Nov 4;10(11):e0141726. doi: 10.1371/journal.pone.0141726. eCollection 2015.

DOI:10.1371/journal.pone.0141726
PMID:26536459
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4633176/
Abstract

Papillary thyroid carcinoma (PTC) is a well-differentiated thyroid tumor that accounts for approximately 80% of thyroid cancer cases. On other hand, anaplastic thyroid carcinoma (ATC) is a less frequent, but aggressive subtype, with poor prognosis. MicroRNAs (miRNAs), small non-coding RNAs, have emerged as potent post-transcriptional regulators of gene expression, which modulate the expression of cancer-related genes. Computational analyses estimate that a single miRNA may modulate hundreds of mRNA targets and, at the same time, cooperate with others to regulate one single mRNA transcript. Due to the large number of predicted targets and possible interactions, only a small number of miRNAs have characterized biological roles, and the panorama of miRNA-mediated regulation in thyroid cancer remains to be understood. Taking into consideration the large amount of gene expression data deposited in public databases we aligned miRNA target prediction and gene expression data from public PTC and ATC datasets to construct a network of post-transcriptional regulation in thyroid cancer. After a gene set enrichment analysis we identified signaling pathways and biological processes potentially modulated by the miRNAs deregulated in PTC and ATC. Our results show miRNA-mRNA interaction that could contribute with the de-regulation of key tumor-host mediators, such as extra-cellular matrix molecules, interleukins and interleukin receptors, which could drive a more aggressive behavior and tumor progression. Moreover, our analysis through The Cancer Genome Atlas (TCGA) database revealed that aberrant expression of ECM and cytokines genes is frequent in PTC and is associated with aggressive behavior and decreased overall survival rate. In conclusion, we shed light on the post-transcriptional regulation of gene expression in differentiated and undifferentiated thyroid cancers, revealing a potential role of miRNAs in modulation of tumor-host interaction molecules, particularly ECM molecules and immune system mediators, which could stimulate crosstalk between tumors and the immune system to generate a more aggressive behavior. We propose a novel putative miRNA:mRNA network that could lead to a new path toward functional studies.

摘要

乳头状甲状腺癌(PTC)是一种分化良好的甲状腺肿瘤,约占甲状腺癌病例的80%。另一方面,间变性甲状腺癌(ATC)是一种较少见但侵袭性强的亚型,预后较差。微小RNA(miRNA)是一类小的非编码RNA,已成为基因表达强有力的转录后调节因子,可调节癌症相关基因的表达。计算分析估计,单个miRNA可能调节数百个mRNA靶标,同时与其他miRNA协同调节单个mRNA转录本。由于预测的靶标数量众多且可能存在相互作用,仅有少数miRNA具有明确的生物学作用,甲状腺癌中miRNA介导的调节全景仍有待了解。考虑到公共数据库中存储的大量基因表达数据,我们将来自公共PTC和ATC数据集的miRNA靶标预测与基因表达数据进行比对,以构建甲状腺癌的转录后调节网络。经过基因集富集分析,我们确定了可能由PTC和ATC中失调的miRNA调节的信号通路和生物学过程。我们的结果显示了miRNA-mRNA相互作用,这可能导致关键肿瘤-宿主介质(如细胞外基质分子、白细胞介素和白细胞介素受体)的失调,从而推动更具侵袭性的行为和肿瘤进展。此外,我们通过癌症基因组图谱(TCGA)数据库的分析表明,细胞外基质和细胞因子基因的异常表达在PTC中很常见,并且与侵袭性行为和总体生存率降低相关。总之,我们揭示了分化型和未分化型甲状腺癌中基因表达的转录后调节,揭示了miRNA在调节肿瘤-宿主相互作用分子(特别是细胞外基质分子和免疫系统介质)中的潜在作用,这可能刺激肿瘤与免疫系统之间的相互作用,从而产生更具侵袭性的行为。我们提出了一个新的假定miRNA:mRNA网络,这可能为功能研究开辟一条新途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/62c4b51f1234/pone.0141726.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/84f4ca95abd9/pone.0141726.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/8146afd69a89/pone.0141726.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/6ef365ab4ca3/pone.0141726.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/45b4b320859b/pone.0141726.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/92c6311855f5/pone.0141726.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/bbe73806d80a/pone.0141726.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/5ef25ecb93ea/pone.0141726.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/71bf9b8c4d3e/pone.0141726.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/d31e02d66710/pone.0141726.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/e38fdba69026/pone.0141726.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/66a011c77733/pone.0141726.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/62c4b51f1234/pone.0141726.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/84f4ca95abd9/pone.0141726.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/8146afd69a89/pone.0141726.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/6ef365ab4ca3/pone.0141726.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/45b4b320859b/pone.0141726.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/92c6311855f5/pone.0141726.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/bbe73806d80a/pone.0141726.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/5ef25ecb93ea/pone.0141726.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/71bf9b8c4d3e/pone.0141726.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/d31e02d66710/pone.0141726.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/e38fdba69026/pone.0141726.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/66a011c77733/pone.0141726.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89fa/4633176/62c4b51f1234/pone.0141726.g012.jpg

相似文献

1
Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.甲状腺癌公共数据集的综合分析揭示了转录后调控通过靶向免疫系统介质对肿瘤进展的作用。
PLoS One. 2015 Nov 4;10(11):e0141726. doi: 10.1371/journal.pone.0141726. eCollection 2015.
2
Identification of key genes and miRNAs markers of papillary thyroid cancer.鉴定甲状腺乳头状癌的关键基因和 miRNA 标志物。
Biol Res. 2018 Nov 10;51(1):45. doi: 10.1186/s40659-018-0188-1.
3
Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer.14q32编码的微小RNA的下调及miR-654-3p在甲状腺乳头状癌中的肿瘤抑制作用
Oncotarget. 2017 Feb 7;8(6):9597-9607. doi: 10.18632/oncotarget.14162.
4
Effect of ret/PTC 1 rearrangement on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.ret/PTC 1重排在甲状腺乳头状癌模型中对转录及转录后调控的影响
Mol Cancer. 2006 Dec 11;5:70. doi: 10.1186/1476-4598-5-70.
5
Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma.侵袭性甲状腺乳头状癌中 microRNA 和 mRNA 表达谱的综合分析。
Mol Med Rep. 2013 Nov;8(5):1353-8. doi: 10.3892/mmr.2013.1699. Epub 2013 Sep 24.
6
BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis.基于生物信息学分析,BCL2 和 hsa-miR-181a-5p 是与甲状腺乳头状癌相关的潜在生物标志物。
World J Surg Oncol. 2019 Dec 16;17(1):221. doi: 10.1186/s12957-019-1755-9.
7
Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma.对失调的微小RNA进行分析有助于鉴别低分化甲状腺癌和乳头状甲状腺癌。
Horm Metab Res. 2009 Jun;41(6):475-81. doi: 10.1055/s-0029-1215593. Epub 2009 Apr 15.
8
Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer.构建并探究甲状腺乳头状癌中 lncRNA 相关 ceRNA 调控网络。
Oncol Rep. 2018 Mar;39(3):1197-1206. doi: 10.3892/or.2018.6207. Epub 2018 Jan 10.
9
Effect of BRAFV600E mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model.BRAFV600E突变对甲状腺乳头状癌模型中转录及转录后调控的影响
Mol Cancer. 2007 Mar 13;6:21. doi: 10.1186/1476-4598-6-21.
10
Serum-based six-miRNA signature as a potential marker for EC diagnosis: Comparison with TCGA miRNAseq dataset and identification of miRNA-mRNA target pairs by integrated analysis of TCGA miRNAseq and RNAseq datasets.基于血清的六种miRNA特征作为子宫内膜癌诊断的潜在标志物:与TCGA miRNA测序数据集的比较以及通过整合分析TCGA miRNA测序和RNA测序数据集鉴定miRNA-mRNA靶标对
Asia Pac J Clin Oncol. 2018 Oct;14(5):e289-e301. doi: 10.1111/ajco.12847. Epub 2018 Jan 30.

引用本文的文献

1
MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools.甲状腺癌中的 microRNAs:以 medullary 甲状腺癌为重点——潜在的治疗靶点和诊断/预后标志物及基于网络的工具。
Oncol Res. 2024 May 23;32(6):1011-1019. doi: 10.32604/or.2024.049235. eCollection 2024.
2
DLK1-DIO3 region as a source of tumor suppressor miRNAs in papillary thyroid carcinoma.DLK1-DIO3区域作为甲状腺乳头状癌中肿瘤抑制性微小RNA的来源
Transl Oncol. 2024 Aug;46:101849. doi: 10.1016/j.tranon.2023.101849. Epub 2024 May 31.
3
regulates cell migration and invasion in papillary thyroid carcinoma.

本文引用的文献

1
Association between BRAF V600E mutation and recurrence of papillary thyroid cancer.BRAF V600E突变与甲状腺乳头状癌复发之间的关联。
J Clin Oncol. 2015 Jan 1;33(1):42-50. doi: 10.1200/JCO.2014.56.8253. Epub 2014 Oct 20.
2
Immune response in thyroid cancer: widening the boundaries.甲状腺癌中的免疫反应:拓展边界
Scientifica (Cairo). 2014;2014:125450. doi: 10.1155/2014/125450. Epub 2014 Sep 25.
3
Nuclear factor κB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8.
调节甲状腺乳头状癌中的细胞迁移和侵袭。
Front Oncol. 2023 Jan 26;13:1039654. doi: 10.3389/fonc.2023.1039654. eCollection 2023.
4
CREB3L1 promotes tumor growth and metastasis of anaplastic thyroid carcinoma by remodeling the tumor microenvironment.CREB3L1 通过重塑肿瘤微环境促进间变性甲状腺癌的生长和转移。
Mol Cancer. 2022 Oct 3;21(1):190. doi: 10.1186/s12943-022-01658-x.
5
MiR-222-3p promotes the proliferation, migration and invasion of papillary thyroid carcinoma cells through targeting SLC4A4.微小RNA-222-3p通过靶向溶质载体家族4成员4促进甲状腺乳头状癌细胞的增殖、迁移和侵袭。
Histol Histopathol. 2021 Nov;36(11):1199-1207. doi: 10.14670/HH-18-387. Epub 2021 Oct 28.
6
Integrated bioinformatics analysis for the identification of key genes and signaling pathways in thyroid carcinoma.用于鉴定甲状腺癌关键基因和信号通路的综合生物信息学分析
Exp Ther Med. 2021 Apr;21(4):298. doi: 10.3892/etm.2021.9729. Epub 2021 Jan 28.
7
Immunological analyses reveal an immune subtype of uveal melanoma with a poor prognosis.免疫分析揭示葡萄膜黑色素瘤具有预后不良的免疫亚型。
Aging (Albany NY). 2020 Jan 18;12(2):1446-1464. doi: 10.18632/aging.102693.
8
Identification of key genes and miRNAs markers of papillary thyroid cancer.鉴定甲状腺乳头状癌的关键基因和 miRNA 标志物。
Biol Res. 2018 Nov 10;51(1):45. doi: 10.1186/s40659-018-0188-1.
9
Integrated Characterization of MicroRNA and mRNA Transcriptome in Papillary Thyroid Carcinoma.甲状腺乳头状癌中MicroRNA和mRNA转录组的综合表征
Front Endocrinol (Lausanne). 2018 Apr 16;9:158. doi: 10.3389/fendo.2018.00158. eCollection 2018.
10
MicroRNAs as Biomarkers in Thyroid Carcinoma.微小RNA作为甲状腺癌的生物标志物
Int J Genomics. 2017;2017:6496570. doi: 10.1155/2017/6496570. Epub 2017 Sep 6.
在甲状腺癌体内模型中,核因子κB依赖的血管生成调节及转移与分泌的白细胞介素-8相关。
J Clin Endocrinol Metab. 2014 Aug;99(8):E1436-44. doi: 10.1210/jc.2013-3636. Epub 2014 Apr 23.
4
Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.肿瘤相关巨噬细胞通过释放CXCL8促进甲状腺乳头状癌的转移潜能。
Carcinogenesis. 2014 Aug;35(8):1780-7. doi: 10.1093/carcin/bgu060. Epub 2014 Mar 6.
5
Colony-stimulating factor 1 potentiates lung cancer bone metastasis.集落刺激因子 1 增强肺癌骨转移。
Lab Invest. 2014 Apr;94(4):371-81. doi: 10.1038/labinvest.2014.1. Epub 2014 Jan 27.
6
Interleukin-10-1082 gene polymorphism is associated with papillary thyroid cancer.白细胞介素-10 - 1082基因多态性与甲状腺乳头状癌相关。
Mol Biol Rep. 2014 May;41(5):3091-7. doi: 10.1007/s11033-014-3169-7. Epub 2014 Jan 28.
7
Association between a functional insertion/deletion polymorphism in IL1A gene and risk of papillary thyroid carcinoma.白细胞介素1A基因功能性插入/缺失多态性与甲状腺乳头状癌风险之间的关联。
Tumour Biol. 2014 Apr;35(4):3861-5. doi: 10.1007/s13277-013-1512-6. Epub 2014 Jan 23.
8
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
9
MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer.miR-222 和 miR-146b 是复发性甲状腺乳头状癌的组织和循环生物标志物。
Cancer. 2013 Dec 15;119(24):4358-65. doi: 10.1002/cncr.28254. Epub 2013 Oct 28.
10
Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer.下调 miR-218-2 及其宿主基因 SLIT3 协同促进甲状腺癌的侵袭和进展。
J Clin Endocrinol Metab. 2013 Aug;98(8):E1334-44. doi: 10.1210/jc.2013-1053. Epub 2013 May 29.